Vevo Therapeutics
About:
Vevo Therapeutics that is combining in vivo data generated at scale with AI to find better targets and drugs to treat more patients.
Website: https://www.vevo.ai
Twitter/X: vevo_ai
Top Investors: General Catalyst, Wing Venture Capital, Mubadala Capital Ventures, AIX Ventures, Camford Capital
Description:
Vevo Therapeutics, a biotechnology startup, searches for better treatments for more patients using their Mosaic in vivo drug discovery platform and next-generation AI algorithms.
Total Funding Amount:
$12M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2022-01-01
Contact Email:
info(AT)vevo.ai
Founders:
Nima Alidoust
Number of Employees:
11-50
Last Funding Date:
2022-12-08
IPO Status:
Private
© 2024 MyAiNote.com